Back to Resource Center

HIV prevention: better choice for better coverage

HIV prevention: better choice for better coverage

Antiretroviral-based pre-exposure prophylaxis (PrEP) is today an established, effective and safe method of HIV prevention used in multiple countries worldwide by a broad range of populations at risk of HIV infection. Biomedical innovations are critical in supporting the primary prevention of HIV; however, their potential can only be maximized if end-user challenges are recognized, described and used to develop next-generation models. This commentary concludes that, in order to ensure that all people have access to prevention options that meet their specific prevention needs, both early and next-generation PrEP options are needed.

View Journal Article

January 2022

Click for full info +

Full Info:


Resource Type:

Journal Article

Citation:

Antiretroviral-based pre-exposure prophylaxis (PrEP) is today an established, effective and safe method of HIV prevention used in multiple countries worldwide by a broad range of populations at risk of HIV infection. Biomedical innovations are critical in supporting the primary prevention of HIV; however, their potential can only be maximized if end-user challenges are recognized, described and used to develop next-generation models.

Authors:

Bekker, Linda-Gail; Pike, Carey; & Hillier, Sharon L.

Health Risks(s):

  • HIV

Product type(s):

  • ARVs

Topic(s):

  • Product Introduction
  • Social

Region(s)

  • Africa
  • Global

Back to Resource Center